Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization Trial (EFFECT-CPE): a Multisite, Open-label, Randomized Controlled Feasibility Pilot Trial

NCT03802461 is registered in ClinicalTrials.gov with Susy Hota as lead sponsor.

NCT NCT03802461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03802461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization Trial (EFFECT-CPE): a Multisite, Open-label, Randomized Controlled Feasibility Pilot Trial
Lead sponsor
Susy Hota
Phase
Phase 2/3
Overall status
Suspended
Start date
March 22, 2019
Completion date
March 20, 2024
Enrollment
40 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

infection